Aims Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely
manner according to evidence‐based clinical guidelines, is a key reason for uncontrolled …

Background: Guidelines differ with regard to indications for initial combination
pharmacotherapy for type 2 diabetes. Aims: To compare the efficacy and safety of (i) sodium …

OBJECTIVE To describe rescue insulin use and associated factors in the Glycemia
Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) …

Introduction Therapeutic inertia refers to the failure to initiate or intensify treatment in a timely
manner and is widespread in type 2 diabetes (T2D) despite the well-established importance …

Introduction Resistance to initiating insulin therapy is common for people with type 2
diabetes (T2D) using multiple oral agents, resulting in sustained poor glycemic control. We …

Background Intensification of metformin monotherapy with additional glucose-lowering
drugs is often required in patients with type 2 diabetes (T2D). This study evaluated changes …

There is clear evidence that achieving glycaemic targets reduces the risk of developing
complications as a result of type 2 diabetes (T2D). Many patients, however, continue to have …

While some incremental and fragmented progress has been made in recent years,
assessing the quality of care provided by pharmacists and pharmacy organizations remains …

Aims: The efficacy and safety of oral semaglutide, the first glucagon-like peptide-1 (GLP-1)
receptor agonist developed for oral administration for the treatment of type 2 diabetes, was …

Aim To explore the safety and effectiveness of extended exposure to bexagliflozin as a
monotherapy for type 2 diabetes. Methods Adults with diabetes (n= 288) from the USA …